Correction to: COVID arm that appeared in the contralateral upper extremity after mRNA‑1273 booster inoculation

por Sanomachi, Tomomi, Sumiyoshi Okuma, Hitomi, Yonemori, Kan
Publicado 2023

COVID arm that appeared in the contralateral upper extremity after mRNA-1273 booster inoculation

por Sanomachi, Tomomi, Sumiyoshi Okuma, Hitomi, Yonemori, Kan
Publicado 2023

Inhibition of the Lipid Droplet–Peroxisome Proliferator-Activated Receptor α Axis Suppresses Cancer Stem Cell Properties

por Kuramoto, Kenta, Yamamoto, Masahiro, Suzuki, Shuhei, Togashi, Keita, Sanomachi, Tomomi, Kitanaka, Chifumi, Okada, Masashi
Publicado 2021

Therapeutic targeting of pancreatic cancer stem cells by dexamethasone modulation of the MKP-1–JNK axis

por Suzuki, Shuhei, Okada, Masashi, Sanomachi, Tomomi, Togashi, Keita, Seino, Shizuka, Sato, Atsushi, Yamamoto, Masahiro, Kitanaka, Chifumi
Publicado 2021

Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson’s disease, as an anti-cancer stem cell drug

por Okada, Masashi, Takeda, Hiroyuki, Sakaki, Hirotsugu, Kuramoto, Kenta, Suzuki, Shuhei, Sanomachi, Tomomi, Togashi, Keita, Seino, Shizuka, Kitanaka, Chifumi
Publicado 2017

In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile

por Suzuki, Shuhei, Yamamoto, Masahiro, Togashi, Keita, Sanomachi, Tomomi, Sugai, Asuka, Seino, Shizuka, Yoshioka, Takashi, Kitanaka, Chifumi, Okada, Masashi
Publicado 2019

Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction

por Suzuki, Shuhei, Yamamoto, Masahiro, Sanomachi, Tomomi, Togashi, Keita, Sugai, Asuka, Seino, Shizuka, Yoshioka, Takashi, Kitanaka, Chifumi, Okada, Masashi
Publicado 2019

Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs

por Sanomachi, Tomomi, Suzuki, Shuhei, Togashi, Keita, Sugai, Asuka, Seino, Shizuka, Okada, Masashi, Yoshioka, Takashi, Kitanaka, Chifumi, Yamamoto, Masahiro
Publicado 2019

Doxazosin, a Classic Alpha 1-Adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug Repurposing

por Suzuki, Shuhei, Yamamoto, Masahiro, Sanomachi, Tomomi, Togashi, Keita, Sugai, Asuka, Seino, Shizuka, Okada, Masashi, Yoshioka, Takashi, Kitanaka, Chifumi
Publicado 2020

Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction

por Suzuki, Shuhei, Yamamoto, Masahiro, Sanomachi, Tomomi, Togashi, Keita, Sugai, Asuka, Seino, Shizuka, Yoshioka, Takashi, Okada, Masashi, Kitanaka, Chifumi
Publicado 2021

Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax

por Yamamoto, Masahiro, Sanomachi, Tomomi, Suzuki, Shuhei, Togashi, Keita, Sugai, Asuka, Seino, Shizuka, Sato, Atsushi, Okada, Masashi, Kitanaka, Chifumi
Publicado 2021

Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction

por Kuramoto, Kenta, Suzuki, Shuhei, Sakaki, Hirotsugu, Takeda, Hiroyuki, Sanomachi, Tomomi, Seino, Shizuka, Narita, Yoshitaka, Kayama, Takamasa, Kitanaka, Chifumi, Okada, Masashi
Publicado 2017

Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells

por Suzuki, Shuhei, Okada, Masashi, Takeda, Hiroyuki, Kuramoto, Kenta, Sanomachi, Tomomi, Togashi, Keita, Seino, Shizuka, Yamamoto, Masahiro, Yoshioka, Takashi, Kitanaka, Chifumi
Publicado 2018

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo

por Takeda, Hiroyuki, Okada, Masashi, Kuramoto, Kenta, Suzuki, Shuhei, Sakaki, Hirotsugu, Sanomachi, Tomomi, Seino, Shizuka, Yoshioka, Takashi, Hirano, Hirofumi, Arita, Kazunori, Kitanaka, Chifumi
Publicado 2017

Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma

por Yamamoto, Masahiro, Sanomachi, Tomomi, Suzuki, Shuhei, Uchida, Hiroyuki, Yonezawa, Hajime, Higa, Nayuta, Takajo, Tomoko, Yamada, Yuki, Sugai, Asuka, Togashi, Keita, Seino, Shizuka, Okada, Masashi, Sonoda, Yukihiko, Hirano, Hirofumi, Yoshimoto, Koji, Kitanaka, Chifumi
Publicado 2021

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer

por Sanomachi, Tomomi, Okuma, Hitomi Sumiyoshi, Kitadai, Rui, Kawachi, Asuka, Yazaki, Shu, Tokura, Momoko, Arakaki, Motoko, Saito, Ayumi, Kita, Shosuke, Yamamoto, Kasumi, Maejima, Aiko, Kojima, Yuki, Nishikawa, Tadaaki, Sudo, Kazuki, Shimoi, Tatsunori, Noguchi, Emi, Fujiwara, Yasuhiro, Sugino, Hirokazu, Shiino, Sho, Suto, Akihiko, Yoshida, Masayuki, Yonemori, Kan
Publicado 2023